Louisiana Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Tech Review.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 24, 2025

$Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia$

October 24, 2025

Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

GlobeNewswire

October 24, 2025

K12 Wins Two Silver Medals at 2025 International Serious Play Awards

GlobeNewswire

October 24, 2025

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference

GlobeNewswire

October 24, 2025

Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

Hera & Circular Revolutionize Traceability & Transparency in Banking, Insurance, Agri-food, and Healthcare

GlobeNewswire

October 24, 2025

Surfshark launches a privacy-first web content blocker

GlobeNewswire

October 24, 2025

Purple unveils ConneX: The mission to free the internet and redefine guest experience

GlobeNewswire

October 24, 2025

Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference

GlobeNewswire

October 24, 2025

Ironwood Academy Launches to Redefine Financial Learning

GlobeNewswire

October 24, 2025

YCTF Industrial Hardware Agency Revolutionizes Supply Chain with Full-Category In-Stock Direct Supply, Offering 30% Cost Savings and 50% Faster Delivery — Trusted by 2,000+ Global Enterprises

GlobeNewswire

October 24, 2025

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors

GlobeNewswire

October 24, 2025

Cyber A.I. Group Expands Seed Round Financing to $6 Million

GlobeNewswire

October 24, 2025

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

GlobeNewswire

October 24, 2025

Snail Games 旗下作品《反抗引擎》在 Steam 新品节表现亮眼，彰显公司产品组合强劲势头

GlobeNewswire

October 24, 2025

《Rebel Engine》於 Steam Next Fest 顯示強勁表現後，Snail Games 重點展示公司產品組合增長動能

GlobeNewswire

October 24, 2025

Crusoe, the AI Factory Company, Raising $1.375 Billion at a Valuation Above $10 Billion to Power the Future of AI Infrastructure

GlobeNewswire

October 24, 2025

Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

GlobeNewswire

October 24, 2025

Remix Therapeutics Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 24, 2025

MicroCloud Hologram Inc. Releases Hybrid Quantum-Classical Convolutional Neural Network, Achieving New Breakthrough in MNIST Multi-Class Classification

GlobeNewswire